Search research articles
Contact Us
Filters
Showing results (151-160 of 186) with videos related to
Page
of 19
Sort By:
The American Journal of Pathology
|
February 20, 2010
Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth
Lei Gu, Ayush Dagvadorj, Jacqueline Lutz, et al.
Age (Dordrecht, Netherlands)
|
June 15, 2016
The trajectory of the blood DNA methylome ageing rate is largely set before adulthood: evidence from two longitudinal studies
L Kananen, S Marttila, T Nevalainen, et al.
Plos One
|
January 23, 2016
Peptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID-9 Cells and Expressed in the Lactating Mouse Mammary Gland
Guangyuan Li, Isaac N Hayward, Brittany R Jenkins, et al.
The American Journal of Pathology
|
May 17, 2008
Stat3 promotes metastatic progression of prostate cancer
Junaid Abdulghani, Lei Gu, Ayush Dagvadorj, et al.
Human Pathology
|
October 3, 2012
Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy
Tuomas Mirtti, Benjamin E Leiby, Junaid Abdulghani, et al.
Endocrinology
|
April 7, 2007
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway
Ayush Dagvadorj, Sean Collins, Jean-Baptiste Jomain, et al.
Molecular Cancer Therapeutics
|
March 1, 2014
Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation
Lei Gu, Pooja Talati, Paraskevi Vogiatzi, et al.
Cancer Research
|
July 17, 2004
Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade
Hongzhen Li, Tommi J Ahonen, Kalle Alanen, et al.
Cancers
|
October 23, 2021
Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?
Paul Beinhoff, Lavannya Sabharwal, Vindhya Udhane, et al.
Cancer Metastasis Reviews
|
October 6, 2021
Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology
William A Hall, Mandana Kamgar, Beth A Erickson, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 186) with videos related to
Sort By:
Page
of 19
The American Journal of Pathology
|
February 20, 2010
Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth
Lei Gu, Ayush Dagvadorj, Jacqueline Lutz, et al.
Age (Dordrecht, Netherlands)
|
June 15, 2016
The trajectory of the blood DNA methylome ageing rate is largely set before adulthood: evidence from two longitudinal studies
L Kananen, S Marttila, T Nevalainen, et al.
Plos One
|
January 23, 2016
Peptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID-9 Cells and Expressed in the Lactating Mouse Mammary Gland
Guangyuan Li, Isaac N Hayward, Brittany R Jenkins, et al.
The American Journal of Pathology
|
May 17, 2008
Stat3 promotes metastatic progression of prostate cancer
Junaid Abdulghani, Lei Gu, Ayush Dagvadorj, et al.
Human Pathology
|
October 3, 2012
Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy
Tuomas Mirtti, Benjamin E Leiby, Junaid Abdulghani, et al.
Endocrinology
|
April 7, 2007
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway
Ayush Dagvadorj, Sean Collins, Jean-Baptiste Jomain, et al.
Molecular Cancer Therapeutics
|
March 1, 2014
Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation
Lei Gu, Pooja Talati, Paraskevi Vogiatzi, et al.
Cancer Research
|
July 17, 2004
Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade
Hongzhen Li, Tommi J Ahonen, Kalle Alanen, et al.
Cancers
|
October 23, 2021
Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?
Paul Beinhoff, Lavannya Sabharwal, Vindhya Udhane, et al.
Cancer Metastasis Reviews
|
October 6, 2021
Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology
William A Hall, Mandana Kamgar, Beth A Erickson, et al.
Page
of 19